2m 2m 2m 2m 2m 2m 2m
ABEONA THERAP (ABEO)
NASDAQ
$7.03+$0.02 (+0.29%)
Price as of Jul 14, 2026 8:25 AM EDT- $399.5MMarket Cap
- 18.41%1-Year Change
- BiotechnologyIndustry
ABEONA THERAP (ABEO)
$7.03+$0.02 (+0.29%)
ABEO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.01 | ||
Change | +$0.03 (+0.43%) | ||
Open | $6.99 | ||
High | $7.08 | ||
Low | $6.66 | ||
Previous Close | $6.98 | ||
Volume | 1,449,744 | ||
30-Day Average Volume | 1,614,032 | ||
1-Week Change | 11.09% | ||
1-Month Change | 26.76% | ||
1-Year Change | 18.41% | ||
3-Year Change | 75.69% | ||
5-Year Change | -79.68% | ||
Fundamentals | |||
Shares Outstanding | 57.0M | ||
Total Assets | $198.5M | ||
Market Cap | $399.5M | ||
Enterprise Value | $356.2M | ||
Period: QTR TTM FY | |||
Revenue | $1.4M | ||
Net Income | -$17.2M | ||
Free Cash Flow | -$20.7M | ||
EBIT | -$16.4M | ||
EBITDA | -$15.7M | ||
Net Working Capital | $151.9M | ||
EPS | -$0.30 | ||
Enterprise Value/EBITDA | -23 | ||
Enterprise Value/Revenue | 263 | ||
P/B | 3 | ||
P/E | -23 | ||
PEG | 1 | ||
Price/Free Cash Flow | -19 | ||
Price/Operating Cash Flow | -20 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 07/05/2022 | ||
Earnings & Revenue